Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction: a randomized, double-blinded, three-arm parallel-group, controlled trial.

Purpose: There is accumulating evidence regarding the potential benefits of empagliflozin in individuals with acute myocardial infarction (MI). Based on the literature, colchicine could also reduce the risk of MI and death in individuals with cardiovascular disease (CVD). However, trials investigati...

Full description

Bibliographic Details

Published in:	European Journal of Clinical Pharmacology Vol. 80; no. 1; pp. 93 - 105
Main Authors:	Khiali, Sajad, Taban-Sadeghi, Mohammadreza, Sarbakhsh, Parvin, Khezerlouy-Aghdam, Naser, Entezari-Maleki, Taher
Format:	research tables/charts randomized controlled trial Journal Article
Published:	Springer Nature Jan2024
Online Access:	View this record in EBSCOhost